Increased monocyte nuclear factor-κB activation and tumor necrosis factor production in alcoholic hepatitis

Journal of Laboratory and Clinical Medicine

Volumn 135, Issue 5, 2000, Pages 387-395

  Hill, Daniell B ^a   Barve, Shirish ^a   Joshi Barve, Swati ^a   McClain, Craig ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL LIVER DISEASE; ENDOTOXIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MONOCYTE; PATHOGENESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR ALPHA;

EID: 0033806903     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1067/mlc.2000.106451     Document Type: Article

References (68)

1. Cytokines and alcoholic liver disease
2. Cytokines in alcoholic liver disease
3. Increased tumor necrosis factor production by monocytes in alcoholic hepatitis
4. Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients
5. Plasma tumor necrosis factor alpha predicts decreased long-term survival in severe alcoholic hepatitis
6. Increased plasma tumor necrosis factor in severe alcoholic hepatitis
7. Immunohistochemical detection of tumor necrosis factor-alpha, other cytokines and adhesion molecules in human livers with alcoholic hepatitis
8. Liver cytokines in alcoholic hepatitis as assessed by immunohistochemistry
9. Endotoxemia, encephalopathy, and mortality in cirrhotic patients
10. Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess
11. Cytokines and liver disease
12. Nuclear factor B: An oxidative stress-responsive transcription factor of eukaryotic cells
13. Increased plasma interleukin-6 concentrations in alcoholic hepatitis
14. Increased plasma interleukin-8 concentrations in alcoholic hepatitis
15. Chapter 1. Hepatitis (571.1). Alcoholic hepatitis
16. Corticosteroid therapy of alcoholic hepatitis
17. HLA-Dr-unrestricted accessory cell function in human neutrophils
18. Multiple nuclear factors interact with the immunoglobulin enhancer sequences
19. Accurate transcription initiation of RNA polymerase II in a soluble extract from isolated mammalian nuclei
20. Message amplification phenotyping (mapping): A technique to simultaneously measure multiple mRNAs from small numbers of cells
21. Semiquantitative analysis of x-linked gene expression during spermatogenesis in the mouse: Ethidium-bromide staining of RT-PCR products
22. Serum levels of interleukin-8 in alcoholic liver disease: Relationship with disease stage, biochemical parameters and survival
23. Hyperhyaluronanemia in alcoholic hepatitis is associated with increased levels of circulating soluble intercellular adhesion molecule-1
24. High interleukin-6 serum levels and increased production by leucocytes in alcoholic liver cirrhosis. Correlation with IgA serum levels and lymphokines production
25. Circulating and tissue levels of the neutrophil chemotaxin interleukin-8 are elevated in severe acute alcoholic hepatitis, and tissue levels correlate with neutrophil infiltration
26. Novel tumor necrosis factor toxic effects. Pulmonary hemorrhage and severe hepatic dysfunction
27. Tumor necrosis factor is a terminal mediator in galactosamine/endotoxin-induced hepatitis in mice
28. Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models
29. Tumor necrosis factor-alpha in galactosamine-induced hepatitis
30. Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat
31. FK506 pretreatment is associated with reduced levels of tumor necrosis factor and interleukin-6 following hepatic ischemia/reperfusion
32. Hepatic ischemia/reperfusion injury: Importance of oxidant/tumor necrosis factor interactions
33. Prevention of carbon tetrachloride-induced rat liver injury by soluble tumor necrosis factor receptor
34. Tumor necrosis factor-alpha and nitric oxide production in endotoxin-primed rats administered carbon tetrachloride
35. 3,3',4,4'-Tetrabromobiphenyl sensitizes rats to the hepatotoxic effects of endotoxin by a mechanism that involves more than tumor necrosis factor
36. Inhibition of acute TCDD toxicity by treatment with anti-TNF antibody or dexamethasone
37. Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-alpha requires transcriptional arrest
38. In vitro tumor necrosis factor cytotoxicity in HepG2 liver cells
39. Cytokine toxicity and induction of NO synthase activity in cultured mouse hepatocytes
40. Activation of the 55 kDa TNF receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis, and nitrite release
41. Endotoxin induced hepatic necrosis in rats on an alcohol diet
42. Tumor necrosis factor in alcohol enhanced endotoxin liver injury
43. Use of reverse transcription-polymerase chain reaction to evaluate in vivo cytokine gene expression in rats fed ethanol for long periods
44. Cytokine gene expression by Kupffer cells in experimental alcoholic liver disease
45. Lactobacillus feeding reduces endotoxemia and severity of experimental alcoholic liver disease
46. Antibiotics prevent liver injury in rats following long-term exposure to ethanol
47. Inactivation of Kupffer cells prevents early alcohol-induced liver injury
48. Differential activation of transcription factors NF-kB and AP-1 in rat liver macrophages
49. Apoptosis: Activate NF-κB or die?
50. Antioxidant and redox regulation of gene transcription
51. Recent advances in tumor necrosis factor and CD40 signaling
52. The effects of acute and chronic alcoholism on tumor necrosis factor and the inflammatory response
53. Inhibition of the Kupffer cell inflammatory response by acute ethanol: NF-kappa B activation and subsequent cytokine production
54. Alcohol-induced regulation of nuclear regulatory factor-kappa beta in human monocytes
55. Acute alcohol consumption attenuates interleukin-8 (IL-8) and monocyte chemoattractant peptide-1 (MCP-1) induction in response to ex vivo stimulation
56. Regulation of the TNFa gene
57. Randomised double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor a (cA2) versus placebo in rheumatoid arthritis
58. Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2)
59. TNF antibodies get new lease
60. Linoleic acid and TNFa cross-amplify oxidative injury and dysfunction of endothelial cells
61. Signal transduction for nuclear factor-kB activation. Proposed location of antioxidant-inhibitable step
62. Vitamin E therapy of acute CC14-induced hepatic injury in mice is associated with inhibition of nuclear factor kappa B binding
63. Inhibition of carbon tetrachloride-induced liver injury by liposomes containing vitamin E
64. Role of oxidative stress and antioxidant therapy in alcoholic and non-alcoholic liver diseases
65. N-acetylcysteine and glutathione as inhibitors of tumor necrosis factor production
66. Cytotoxicity and apoptosis produced by arachidonic acid in Hep G2